Drug Type Small molecule drug |
Synonyms SND 504, SND504 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leukemia | Preclinical | Switzerland | 22 Mar 2024 | |
| Leukemia | Preclinical | Switzerland | 22 Mar 2024 | |
| Lymphoma | Preclinical | Switzerland | 22 Mar 2024 | |
| Lymphoma | Preclinical | Switzerland | 22 Mar 2024 | |
| Solid tumor | Preclinical | Switzerland | 22 Mar 2024 | |
| Solid tumor | Preclinical | Switzerland | 22 Mar 2024 |





